Search

everythinglearnresearchcommunity

for

Search:↓

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

Estrogen increases a growth factor in hair cells which might affect hair loss.

Applying latanoprost on skin can stimulate hair growth with minimal side effects.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Combining corticosteroids and non-ablative fractional laser therapy may effectively treat extensive alopecia areata.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Alopecia areata may be linked to heart issues.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

The monkey's hair loss was due to an autoimmune disease, not genetics.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Stress may trigger hair loss by affecting immune protection in hair follicles.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.